Pages

Friday, May 25, 2012

Group Issues New Guidelines For Screening, Treating Lupus Nephritis.

HealthDay Share to FacebookShare to Twitter (5/4, Gordon) reports that the American College of Rheumatology has crafted new guidelines for the screening and management of a "potentially devastating complication of lupus" involving the presence of kidney inflammation in patients. This condition, also known as lupus nephritis, "can lead to end-stage-renal disease, which requires dialysis or a kidney transplant," according to lead author Dr. Bevra Hahn, chief of rheumatology at the David Geffen School of Medicine at the University of California, Los Angeles. Hahn adds that "not all types are this serious. It depends on the pattern of damage to the kidneys." HealthDay notes that the guidelines recommend a kidney biopsy if a patient has not received treatment for lupus nephritis and has shown signs of kidney involvement. The information from the biopsy helps doctors decide what treatments to prescribe.
        WebMD Share to FacebookShare to Twitter (5/4, Mann) mentions that "about 1.5 million Americans have lupus, and one-third of them will develop kidney involvement, or lupus nephritis, as a result, according to the Lupus Foundation of America." The new ACR guidelines on lupus nephritis appear in the journal Arthritis Care & Research.

No comments:

Post a Comment